Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging
- PMID: 24434293
- DOI: 10.2967/jnumed.113.128397
Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging
Abstract
Antimicrobial peptides such as ubiquicidin (UBI) are believed to differentiate between mammalian and bacterial or fungal cells. (99m)Tc-UBI29-41 was previously tested for detecting infection in humans using SPECT. For the present study, the UBI fragment UBI29-41 (TGRAKRRMQYNRR) was conjugated to 1,4,7-triazacyclononane-triacetic acid (NOTA), radiolabeled with (68)Ga, and investigated in a rabbit infection model.
Methods: (68)Ga was obtained from a 1.85-GBq (68)Ge/(68)Ga generator. New Zealand White rabbits were anesthetized with ketamine/medetomidine before tracer administration and placed in a clinical PET/CT scanner. (68)Ga-1,4,7-triazacyclononane-1,4,7-triacetic-acid-ubiquicidin29-41 ((68)Ga-NOTA-UBI29-41) was formulated in saline solution, and 101 ± 41 MBq were administered intravenously. The tracer distribution was studied by PET/CT imaging in animals (a) that were healthy, (b) bearing muscular Staphylococcus aureus infections and turpentine oil-induced muscular inflammations, and (c) bearing ovalbumin-induced lung inflammations. Static PET/CT imaging was performed at different time intervals up to 120 min after injection. For calculation of target-to-nontarget ratios, standardized uptake values were normalized against healthy thigh muscle, representing nontargeted tissue.
Results: PET/CT images of healthy animals showed predominant distribution in the kidneys, liver, and bladder; heart and spleen showed moderate, declining uptake, only. The biologic half-life in blood was 29 min. Urinary accumulation of (68)Ga-NOTA-UBI29-41 peaked at 3.8 ± 0.91 percentage injected dose per gram (%ID) at 120 min, and 88 ± 5.2 %ID was recovered in total urine. (68)Ga-NOTA-UBI29-41 imaging in (b) selectively visualized the muscular infection site and was differentiated from sterile inflammatory processes. Standardized uptake value ratios for muscles (infected/inflamed) were 2.9 ± 0.93, 2.9 ± 0.50, 3.5 ± 0.86, and 3.8 ± 0.90 at 5, 30, 60, and 90 min after injection, respectively. Rabbit lungs with asthma showed insignificant uptake.
Conclusion: (68)Ga-NOTA-UBI29-41 was strongly localized in bacteria-infected areas and minimally detected in a sterile inflammation area in rabbit muscles. The findings propose this compound to be an excellent first-line PET/CT tracer to allow the distinguishing of infection from inflammation.
Keywords: 68Ga labeling; PET/CT Imaging; UBI29-41; infection; ubiquicidin.
Similar articles
-
Peptide synthesis, characterization and ⁶⁸Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET/CT.Nucl Med Biol. 2014 May-Jun;41(5):390-400. doi: 10.1016/j.nucmedbio.2014.02.001. Epub 2014 Feb 13. Nucl Med Biol. 2014. PMID: 24630816
-
68Ga-NOTA-Functionalized Ubiquicidin: Cytotoxicity, Biodistribution, Radiation Dosimetry, and First-in-Human PET/CT Imaging of Infections.J Nucl Med. 2018 Feb;59(2):334-339. doi: 10.2967/jnumed.117.200048. Epub 2017 Oct 19. J Nucl Med. 2018. PMID: 29051342 Clinical Trial.
-
⁶⁸Ga-NOTA-UBI-29-41 as a PET Tracer for Detection of Bacterial Infection.J Nucl Med. 2016 Apr;57(4):622-7. doi: 10.2967/jnumed.115.161265. Epub 2016 Jan 14. J Nucl Med. 2016. PMID: 26769861
-
(68)Ga-radiopharmaceuticals for PET imaging of infection and inflammation.Recent Results Cancer Res. 2013;194:189-219. doi: 10.1007/978-3-642-27994-2_11. Recent Results Cancer Res. 2013. PMID: 22918761 Review.
-
99mTc-Labeled poly(ethyleneglycol)–N-(N-(3-diphenylphosphinopropionyl)glycyl)-S-tritylcysteine (PEG-PN2S)-linked ubiquicidin (UBI).2011 Sep 26 [updated 2011 Oct 28]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Sep 26 [updated 2011 Oct 28]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 22073422 Free Books & Documents. Review.
Cited by
-
A Systematic Approach for Developing Bacteria-Specific Imaging Tracers.J Nucl Med. 2017 Jan;58(1):144-150. doi: 10.2967/jnumed.116.181792. Epub 2016 Sep 15. J Nucl Med. 2017. PMID: 27635025 Free PMC article.
-
Synthesis, 68Ga-radiolabeling, and preliminary in vivo assessment of a depsipeptide-derived compound as a potential PET/CT infection imaging agent.Biomed Res Int. 2015;2015:284354. doi: 10.1155/2015/284354. Epub 2015 Jan 28. Biomed Res Int. 2015. PMID: 25699267 Free PMC article.
-
Radiotracer Development for Fungal-Specific Imaging: Past, Present, and Future.J Infect Dis. 2023 Oct 3;228(Suppl 4):S259-S269. doi: 10.1093/infdis/jiad067. J Infect Dis. 2023. PMID: 37788500 Free PMC article. Review.
-
PET Radiopharmaceuticals for Specific Bacteria Imaging: A Systematic Review.J Clin Med. 2019 Feb 6;8(2):197. doi: 10.3390/jcm8020197. J Clin Med. 2019. PMID: 30736324 Free PMC article. Review.
-
Molecular imaging of bacterial infections: Overcoming the barriers to clinical translation.Sci Transl Med. 2019 Sep 4;11(508):eaax8251. doi: 10.1126/scitranslmed.aax8251. Sci Transl Med. 2019. PMID: 31484790 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources